No Delays Expected As Australian Bill On Faster Drug Approvals Goes To Parliament
Executive Summary
The Australian parliament has held its first reading of a bill that will implement a number of new measures in the pharmaceutical area, including two new expedited drug approval pathways and a risk-based approach to variations.
You may also be interested in...
Black Triangle Scheme And Formal Inspections On the Cards In Australia
New pharmacovigilance-enhancing proposals from Australia’s Therapeutic Goods Administration signal the agency’s intention to become more proactive when it comes to monitoring drug sponsors.
Australian Provisional Approval Pathway To Get Tough On Sponsors Upfront
Plans by Australia’s Therapeutic Goods Administration to develop a provision approval pathway for drugs have moved up a gear.
Australia Steps Up Priority Review And Faster Assessment Plans
The Therapeutic Goods Administration is seeking feedback on proposals for a priority-review pathway and a system for designating Australian conformity assessment bodies. Both efforts promise to speed products to market and might also involve new fees for industry.